Talita Glaser Selected Research

Talita Glaser Research Topics

Disease

7	Neoplasms (Cancer) 09/2023 - 01/2012
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2013
4	Inflammation (Inflammations) 01/2023 - 01/2018
4	COVID-19 12/2022 - 01/2021
3	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2015
3	Neuroblastoma 09/2023 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2022
2	Huntington Disease (Huntington's Disease) 06/2021 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 11/2019
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2020
1	Carcinogenesis 09/2023
1	Neurobehavioral Manifestations 01/2023
1	Spontaneous Abortion (Miscarriage) 01/2023
1	Cytokine Release Syndrome 12/2022
1	Neuroinflammatory Diseases 12/2022
1	Pain (Aches) 12/2022
1	Autism Spectrum Disorder 01/2022
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Parkinson Disease (Parkinson's Disease) 11/2020
1	Basal Ganglia Diseases (Basal Ganglia Disease) 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Lung Neoplasms (Lung Cancer) 11/2015

Drug/Important Bio-Agent (IBA)

8	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2021
4	Purinergic P2X7 ReceptorsIBA 01/2022 - 01/2018
4	Purinergic Receptors (Receptors, Purine)IBA 01/2021 - 11/2015
4	BradykininIBA 01/2021 - 01/2016
3	NucleotidesIBA 01/2022 - 11/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2023
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2012
2	PurinesIBA 01/2022 - 01/2018
2	Uridine Triphosphate (UTP)IBA 01/2021 - 11/2015
2	Purinergic P2Y2 ReceptorsIBA 01/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	Metalloproteases (Metalloproteinases)IBA 01/2018 - 01/2016
2	KininsIBA 01/2018 - 01/2016
1	Proline (L-Proline)FDA Link 09/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2023
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 09/2023
1	Bothrops jararaca VenomIBA 09/2023
1	Presenilin-1IBA 01/2023
1	Caffeine (No Doz)FDA LinkGeneric 01/2023
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2023
1	Neuroprotective AgentsIBA 01/2023
1	TRPV1 receptorIBA 12/2022
1	CannabidiolIBA 12/2022
1	CannabinoidsIBA 12/2022
1	Therapeutic UsesIBA 12/2022
1	EndocannabinoidsIBA 12/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	GinkgolidesIBA 01/2022
1	RetinoidsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	huperzine AIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2022
1	Purine NucleotidesIBA 06/2021
1	polyglutamineIBA 06/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Calcium Channels (Calcium Channel)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	CalciumIBA 11/2019
1	Kininogens (Kininogen)IBA 01/2019
1	coomassie Brilliant BlueIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	purineIBA 01/2018
1	CRISPR-Associated Protein 9IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Adenosine DeaminaseIBA 01/2012
1	EnzymesIBA 01/2012

Therapy/Procedure

6	Therapeutics 09/2023 - 01/2017
3	Drug Therapy (Chemotherapy) 09/2023 - 11/2015
1	Radiotherapy 09/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Chemoradiotherapy 11/2015
1	Transplantation 01/2013